Dr. Bohnen attended medical school in the Netherlands and completed a PhD in neuropsychology. He completed residency training in neurology (Mayo Clinic), and nuclear medicine (University of Michigan) with additional movement disorders training. As a dual-board certified neurologist and nuclear medicine physician he practices at Michigan Medicine and the Ann Arbor VA Healthcare System. He is the Director of the UM Functional Neuroimaging, Cognitive and Mobility Laboratory where his research interests include the use of PET and MRI as mechanistic, diagnostic, prognostic and clinical trial outcome measures in the study of normal aging, muscular frailty, sedentarism, prodromal and clinically manifest Parkinson’s disease and related Lewy body dementias. His group has helped to identify cholinergic denervation as a prominent factor related to dementia, REM sleep behavior disorder, hyposmia, falls and freezing of gait in Parkinson disease. His research is funded by grants from the NIH, VA and foundations, including the The Michael J. Fox Foundation.
Associated Grants
-
-
The Role of Amyloid in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study
2012
-
-